In response to ROS increase following chemical inhibition or genetic deletion of TrxR1, cancer cells acquire adaptive mechanisms, such as increased NRF2, to enhance the GSH antioxidant compensation mechanism and evade cell death. This evidence concerns the gene TXNRD1 and cancer.